Stevanato Group to Report Second Quarter 2022 Financial Results on August 4, 2022Business Wire • 07/22/22
Stevanato Group Releases Sustainability Report 2021, Highlighting the Environmental, Social and Governance (ESG) Performance of the GroupBusiness Wire • 06/13/22
Stevanato Group Adding New Capacity in Italy Amid Growing Demand for Its Market-Leading SolutionsBusiness Wire • 05/31/22
Stevanato Group S.p.A. (STVN) CEO Franco Moro on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/14/22
Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-InjectorBusiness Wire • 05/04/22
Stevanato Group S.p.A. and Bexson Biomedical, Inc. Expand Collaboration to Treat a Range of Mental Health Conditions With an On-body DeviceBusiness Wire • 04/29/22
Stevanato Group to Report First Quarter 2022 Financial Results on May 10, 2022Business Wire • 04/27/22
Stevanato Group Files Amendment No.1 to Its 2021 Annual Report on Form 20‑F/ABusiness Wire • 04/05/22
Stevanato Group S.p.A. (STVN) CEO Franco Moro on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/08/22
Stevanato Group Announces Agreement With BARDA for the Expansion of Vial Production to Create Industrial Base Capabilities for National DefenseBusiness Wire • 03/01/22
Stevanato Group Extends Pen Injector Technology Licensing Agreement With HaselmeierBusiness Wire • 01/26/22
Stevanato Group S.p.A. (STVN) CEO Franco Moro on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
Stevanato Group Reports Strong Third Quarter 2021 Revenue and Financial Results and Updates Full Year 2021 GuidanceBusiness Wire • 11/09/21